Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

6.78
Delayed Data
As of Aug 04
 +0.20 / +3.04%
Today’s Change
3.05
Today|||52-Week Range
8.61
-15.36%
Year-to-Date

Today’s Trading

Previous close6.58
Today’s open6.65
Day’s range6.59 - 6.82
Volume294,937
Average volume (3 months)319,312
Market cap$247.4M
Dividend yield--
Data as of 3:59pm ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)+66.94%
Earnings growth (this year)-176.59%
Earnings growth (next 5 years)--
Revenue growth (last year)+53.16%
P/E ratioNM
Price/Sales6.09
Price/Book2.68

Competitors

 Today’s
change
Today’s
% change
RIGLRigel Pharmaceutical...+0.09+2.93%
NATRNatures Sunshine Pro...+0.39+3.11%
NUTRNutraceutical Intern...+0.64+2.70%
CDTXCidara Therapeutics ...-0.22-1.52%
Data as of 3:59pm ET, 08/04/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$46.9M
Annual profit (last year)-$14.6M
Net profit margin-31.20%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Sharon A. Barbari
Corporate headquarters
South San Francisco, California

Forecasts